Showing results (81-90 of 496) with videos related to

Sort By:
Pageof 50
Immunity|June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodiesNadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Early innate immune signatures correlate with Ad26.COV2.S vaccine durability and protective efficacyAlessandro Colarusso, Kathryn Stephenson, Ai-Ris Collier, et al.
Journal of Virology|September 12, 2014
Common features of mucosal and peripheral antibody responses elicited by candidate HIV-1 vaccines in rhesus monkeysHualin Li, Kathryn E Stephenson, Zi Han Kang, et al.
Cell|March 19, 2021
Novel approaches for vaccine developmentMakda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Current Opinion in Virology|August 7, 2016
The sooner the better: innate immunity as a path toward the HIV cureJeffrey Tomalka, Khader Ghneim, Sanghamitra Bhattacharyya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 26, 2025
Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era: A systematic review and meta-analysisAkvile Chapman, Dan H Barouch, Gregory Y H Lip, et al.
Retrovirology|October 26, 2013
GagPol-specific CD4⁺ T-cells increase the antibody response to Env by intrastructural helpGhulam Nabi, Michael Storcksdieck Genannt Bonsmann, Matthias Tenbusch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2002
BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patientDan H Barouch, William C Faquin, Yiping Chen, et al.
Journal of Virology|November 27, 2004
Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitopeFred W Peyerl, Heidi S Bazick, Michael H Newberg, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2020
Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infectionElena Bekerman, Stephanie Cox, Darius Babusis, et al.
Pageof 50